Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOHN W. who wrote (2096)	10/4/1997 1:26:00 PM
From: sam	of 6136

John: I agree. Agouron's stock price has been moving almost exclusively on the predictions of Viracept sales going forward. It would be useful for us all to learn more about the rest of their pipeline. Since, at this point at least, it seems that investors are getting several other potential products for the price of one blockbuster. Obviously, there's much more risk associated with those other drugs. But what are the potential gains?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next